Report: Abingworth tees up $330M-plus to bankroll biotech bets

Damian Garde

Life sciences venture outfit is creeping up on a close for its 6th fund, according to Dow Jones Venturewire, reportedly outstripping its goal of $ 330 million as it stocks up for another round of investments.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS